TriSalus Life Sciences, Inc. (TLSI) short interest & options flow
NASDAQTriSalus Life Sciences enters Thursday's aftermath carrying a guidance cut, a target-price trim, and short interest at a six-week high — all in the same 48-hour window. The trigger was Tuesday's Q1 print. Revenue came in at $8.9M, missing the $10.4M consensus. EPS of $0.03 beat the $(0.16) estimate — an unusual combination of a top-line miss and a bottom-line beat. More damaging…
- Market cap
- $142M
- Next earnings
- 5 Mar 2027
Key data as of 12 Nov 2026

TLSI news and analysis
RSSNo long-form analysis yet for TLSI. Pulse alerts and the live data picture are available on ORTEX.
Open TLSI on ORTEX →Want the live picture for TLSI?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TLSI — free to start on ORTEX.
Sign up for free →Open TLSI on ORTEX